main st. salad corp.

po box 670832
flushing, new york 11367

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 10, 2013

NYS DOS ID#
4428804

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - MAIN ST. SALAD CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Pasta Salad Sheds Some Carbs for Summer
    Thursday Jun 15, 2017

    Pasta salad lightens up nicely with a reduced carbs-to-crunch ratio. These recipes, for a veggie-forward version and a richer one with roast chicken and blue cheese, redefine the summertime classic.

    Source: The Wall Street Journal: Lifestyle
  • Salad Kits And Snack Packs Recalled For Potential Listeria Contamination
    By Laura Northrup - Monday Jun 12, 2017

    When you opt to eat a salad or some precut fruits and vegetables for a snack, you’re usually making a healthier decision. But some salad and snack kits, most of which were sold at Kroger-owned stores, have been recalled for potential contamination with Listeria, a foodborne pathogen that can have life-threatening complications. Affected products came from CC Kitchens in Ohio, …

    Source: The Consumerist
  • Greg David on NY: Why developing in Midtown remains a Herculean task
    Monday Jun 19, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session
    By Jeff Engel - Wednesday Jun 14, 2017

    The refrain among digital health startups is it can be difficult and time-consuming to convince hospitals and other healthcare organizations to try out their products, let alone buy them. Pulse@MassChallenge, a new Boston “lab” dedicated to supporting digital health ventures, matches startups with partner organizations—think hospitals, insurers, larger tech companies, nonprofits, and government entities—to collaborate […]

    Source: Xconomy VC, Deals, & Startups Feed
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • New Approvals Show FDA Is Adapting to Precision Medicine
    By Frank Vinluan - Tuesday May 30, 2017

    The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week. The […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Economic Study Ranks San Diego Near Top in Genomics Innovation
    By Bruce V. Bigelow - Tuesday Jun 20, 2017

    An economic impact study of San Diego’s emerging genomics industry counted 115 genomics-related companies operating in the region that directly employ over 10,000 people, and drive about $5.6 billion worth of annual economic benefits throughout the area. “San Diego is really end-to-end in genomics, from start to finish,” said Kirby Brady, who oversaw the study […]

    Source: Xconomy VC, Deals, & Startups Feed